Korean J Physiol Pharmacol.  1998 Jun;2(3):369-376.

Hydroxyl radical-mediated commitment of HL-60 cells to differentiation: Modulation of differentiation process by phosphodiesterase inhibitors

Affiliations
  • 1Dep. Pharmacol., Catholic Univ. Med. College, 505 Banpo-dong, Seocho-gu, Seoul 137-701 South Korea.

Abstract

Ms report shows that hydroxyl radical, generated by a Fenton reaction involving adenosine 5'-diphosphate/Fe2+ complex (5-15 micrometer) and H2O2 (2 micrometer), induced differentiation of HL-60 cells in a dose- and time-dependent manner. This is evidenced by the increases in 12-O-tetradecanoylphorbol 13-acetate- and fMLP-stimulated superoxide production capability. The cells exposed to hydroxyl radical for defined periods (24~96 hr) continued to differentiate even after the hydroxyl radical generating system had been removed. The differentiated cells displayed fMLP-stimulated calcium mobilization and increased expression of myeloid-specific antigen CD11b and CD14. The extent of the differentiation was markedly reduced by desferrioxamine (100micrometer), dimethylthiourea (5 mM), N,N'-diphenyl-1,4-phenylenediamine (2 micrometer), and N-acetyl-L-cysteine (5 mM). The induction of differentiation by hydroxyl radical was enhanced by 3-isobutyl-1-methylxanthine (200 micrometer) and Ro-20-1724 (8 micrometer), and inhibited by dipyridamole (2 micrometer). These results suggest that hydroxyl radicals may induce commitment of HL-60 cells to differentiate into more mature cells of myelomonocytic lineage through specific signal-transduction pathway that is modulated by phosphodiesterase inhibitors.


MeSH Terms

1-Methyl-3-isobutylxanthine
Acetylcysteine
Adenosine
Calcium
Deferoxamine
Dipyridamole
HL-60 Cells*
Humans
Hydroxyl Radical
Phosphodiesterase Inhibitors*
Superoxides
1-Methyl-3-isobutylxanthine
Acetylcysteine
Adenosine
Calcium
Deferoxamine
Dipyridamole
Hydroxyl Radical
Phosphodiesterase Inhibitors
Superoxides
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr